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Blunt thoracic aortic injury (BTAI) is a rare, but lethal, consequence of rapid deceleration events. Most victims of BTAI die at
the scene of the accident. Of those who arrive to the hospital alive, expedient aortic intervention signiﬁcantly improves survival.
Thoracic endovascular aortic repair (TEVAR) has been accepted as the standard of care for BTAI at many centers, primarily due to
theconvincingevidenceoflowermortalityandmorbidityincomparisontoopensurgery.However,lessattentionhasbeengivento
potentiallong-termcomplicationsofTEVARforBTAI.Thispaperfocusesonthesecomplications,whichincludeprogressiveaortic
expansion with aging, inadequate stent graft characteristics, device durability concerns, long-term radiation exposure concerns
from follow-up computed tomography scans, and the potential for (Victims of Modern Imaging Technology) VOMIT.
1.Background
Blunt thoracic aortic injury (BTAI) is a leading cause of
mortality in trauma patients, accounting for 8,000 deaths
per year in North America [1]. Automobile accidents are
responsible for most of these injuries [1, 2] although BTAI
from autopedestrian collisions [3], aircraft accidents [4],
falls [5], and crush injuries [6] has been reported. Rapid
deceleration causes shearing forces at the aortic isthmus,
acute diaphragmatic compression, aortic torsion, and aortic
compression between the spine and sternum. Deceleration-
induced BTAI typically results in a transverse aortic tear near
the ligamentum arteriosum [2, 7] ranging in severity from a
partial circumferential intimal tear that may spontaneously
heal with no intervention to complete aortic transection
resulting in rapid exsanguination and death. Approximately,
80–90% of BTAI victims die before reaching the hospital [6,
8]. Of the patients who arrive at the hospital alive, mortality
is 65% unless aortic repair with open surgery or thoracic
endovascular aortic repair (TEVAR) is performed [9].
Until recently, surgical repair of the aorta was the
standard of care for BTAI management. Most cases involve
surgical interposition of a synthetic graft with active bypass
to achieve distal aortic perfusion although simple repair can
be undertaken for minimal aortic injuries. However, surgical
aortic repair is associated with signiﬁcant mortality and
morbidity. Since the ﬁrst report of TEVAR for treatment of
BTAI in 1997 [10], this procedure has become standard of
care at many sites due to the avoidance of left thoracotomy,
aortic cross-clamping, single-lung ventilation, and systemic
anticoagulation and because of the superior short-term
outcomes relative to open surgery. Currently, no endograft
has been approved for the treatment of BTAI, and, therefore,
experience with these devices is limited to clinical trials at
centers of excellence or to oﬀ-label use.
2. Treatments for Blunt Thoracic Aortic Injury
The clinical beneﬁt of aortic repair following BTAI, regard-
less of the method used, is obvious. With nonsurgical man-
agement of BTAI, mortality is approximately 1% per hour
over the ﬁrst 48 hours [6]. Aortic intervention signiﬁcantly
alters the natural history of BTAI with TEVAR oﬀering
short-term beneﬁts over surgical repair. Hoﬀer et al. [11]
reviewed 19 studies that compared TEVAR to open surgery
for treatment of BTAI. TEVAR was associated with lower
risk of mortality (OR = 0.43) and paraplegia (OR =
0.30). A meta-analysis by Xenos and colleagues [12]r e po rt ed
similar outcomes favoring TEVAR with an odds ratio of2 The Scientiﬁc World Journal
0.44 and 0.32 for mortality and paraplegia, respectively.
The following year, this same group updated these ﬁnd-
ings with similar results [13]. Tang et al. reported that
TEVAR reduced mortality by 50% versus open surgery and
resulted in no paraplegia (versus 5.6% for surgery) [14].
Finally, in a prospective nonrandomized multicenter trial,
TEVAR resulted in superior results versus open surgery in
mortality (7.2% versus 23.5%) but no statistical diﬀerence
in paraplegia (0.8% versus 2.9%) [15]. On balance, in
unselected populations, TEVAR oﬀers no survival advantage
o rr e d u ct i o ni np a ra p l egi ari s k[ 16]. This observation may be
attributable to the higher rates of complications with TEVAR
for BTAI at less-experienced centers [15].
The primary goal in the treatment of a BTAI patient is
survival, and, therefore, favorable short-term outcomes are
imperative. However, comparatively less attention has been
given to potential long-term outcomes of TEVAR for BTAI.
To date, no trials of TEVAR for BTAI have reported long-
termclinicalorradiographicoutcomes.Thispaperwillfocus
on the potential long-term complications in patients treated
with TEVAR for BTAI, including progressive aortic expan-
sion with aging, inadequate stent graft characteristics, device
durability concerns, long-term radiation exposure concerns
from follow-up computed tomography scans, and the poten-
tial for VOMIT (Victims of Modern Imaging Technology).
3. PotentialComplications of
EndovascularStent Graftingfor
B l un tT h o rac icA o rticI n j ury
3.1. Aortic Expansion over the Lifespan. The healthy thoracic
aorta increases in diameter by approximately 1.5mm per
decade and, therefore, could theoretically grow almost
10mm from adolescence to old age [17]. Recommended
sizing of stent grafts for BTAI ranges from 0 to 20% larger
than the aortic diameter. Based on these guidelines, a 27mm
diameter stent graft could safely accommodate an aorta of
22.5 to 27mm in diameter. However, if a patient with a
24mm diameter aorta is treated with a 27mm device, the
aorta may expand beyond the diameter of the stent graft
in approximately 20 years, assuming the stent graft did not
inﬂuence aortic growth. This degree of expansion would
greatlyincreasetheriskfordevicecollapse,migration,and/or
endoleakand,intheabsenceofdeﬁnitivesurgicalrepair,may
require multiple TEVAR reinterventions over a lifetime to
account for this progressive growth. Forbes and coworkers
reviewed computed tomography scans from 21 patients who
underwentTEVARforBTAIandhadatleast1-yearfollow-up
imaging. Of concern, the aortic diameter immediately distal
to the left subclavian artery increased at a rate of 0.8mm per
year over a mean 2.6 year follow-up period [18]—a rate of
aortic expansion 5-fold faster than in the healthy aorta. The
behavior of the aorta beyond this period is unknown, but
these data further highlight the need for regular surveillance
in these patients. Concerns around aortic growth may be
somewhat tempered by the fact that placement of endografts
results in ﬁbrous reactions around the graft, which promotes
aorta-to-graft adherence [17, 19].
3.2. Inadequate Stent Graft Characteristics. Advancements
in stent graft technology have severely lagged behind the
widespread oﬀ-label adoption of TEVAR for treatment of
various aortic pathologies. Of the three thoracic stent grafts
currently approved for use in the United States (Medtronic
Talent, Cook TX2, and Gore TAG), none is indicated for use
in the trauma patient. Furthermore, since these devices were
approved for use in patients with degenerative aortic disease,
the characteristics of current devices are less than ideal
for BTAI patients. The ideal trauma-speciﬁc device would
accommodate delivery through small access vessels and
deployment in a small-diameter aorta with tight curvature
of radius in the aortic arch and relatively higher pulsatile
compliance and ﬂow velocity.
The mean aortic diameter adjacent to a BTAI is 19mm
with the smallest reported to be 14mm [2]. However,
availablestentgraftscannotaccommodatetheentirerangeof
aortic diameters in the typical BTAI patient. Consequently,
many BTAI patients are either denied TEVAR due to small
aortic diameter or are treated with excessively oversized,
oﬀ-label devices. The tight angulation of the aortic arch
in the young trauma patient poses additional challenges to
correct endograft placement. Since most BTAIs occur near
the ligamentum arteriosum with a mean 5.8mm length
between the injury and the left subclavian artery ostium
when measured along the lesser curve [2], the proximal
landing zone of the endograft is generally just distal to the
left subclavian artery ostium or, in some cases, distal to
the left common carotid artery necessitating coverage of the
left subclavian artery. The combination of a landing zone
in a tight aortic arch with a relatively inﬂexible stent graft
can result in bird beaking, a phenomenon characterized by
malapposition of the stent graft with the aortic wall, which is
associated with a 64% endoleak rate and a known risk factor
for subsequent device collapse [20].
Device collapse is a phenomenon observed in 1% to
19% of TEVAR repairs for BTAI and is primarily attributable
to excessive device oversizing combined with a tight aortic
curvature radius [21]. In fact, the typical collapsed endograft
is oversized by 27 ± 12% [22]. While typically noted
within 30 days of treatment, device collapses have been
reported after 3 years after TEVAR [21]. Device collapses
have been most commonly reported with the Gore TAG
device with 169 reported collapses, of which 72% required
reintervention and 8% resulted in death, according to the
manufacturer’s 2011 Annual Clinical Update [23]. Further,
it has been suggested that the radial strength of the Gore
TAG device is insuﬃcient to prevent device infolding
when the inferior edge of the device protrudes into the
aortic lumen, particularly with an oversized device in a
small aorta [24]. In contrast, the Talent and TX2 devices
are purported to have relatively superior radial strength
with extremely rare device collapses reported [21, 24, 25].
These data suggest that endograft selection may inﬂuence
treatment outcomes of BTAI. Clinical trials are underway
with trauma-speciﬁc devices that have more sizing options,
better radial strength, and better conformability to the
aortic arch, thereby potentially minimizing the bird beaking
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3.3. Device Durability Concerns. Clinical trials of endovas-
cular stent grafts regulated by the Food and Drug Adminis-
tration typically mandate patient followup for 5 years after
treatment. Pulsatile fatigue testing of thoracic endografts
is generally simulated over 400 million cycles, equivalent
to 10 years in vivo. These durations are adequate for the
study of thoracic aortic aneurysm since the typical patient
lifespan after TEVAR is 7 years [26]. However, for the BTAI
patient treated with TEVAR with an expected lifespan of
severaldecades,long-termdevicedurabilitybecomesamajor
concern and current stent graft evaluation methods are likely
inadequate. To date, the longest reported mean follow-up
duration following TEVAR for BTAI is 8.7 years [27]w i t h
no signiﬁcant survival advantage reported over open surgery
through 4 years (11% versus 16%, P = 0.7) [28]. Beyond
this period, clinical outcomes are unknown. Stent graft
manufacturers should consider extended durability testing
fortrauma-speciﬁcstentgraftscommensuratewithextended
posttreatment patient life spans. Furthermore, regulators
should consider mandating longer follow-up periods for
clinical trials of TEVAR for BTAI in order to collect, at a
minimum, mortality and device-speciﬁc data.
3.4. Excessive Cumulative Radiation Exposure. Helical CT
scans of the chest have become the diagnostic tool of
choice for patients with suspected deceleration injury. A
single chest CT exposes a patient to approximately 7mSv
of ionizing radiation. For reference, a single exposure to
10mSv of ionizing radiation will ultimately cause cancer
in 1 out of 1,000 people [29]. Assuming a 40-year-old
trauma patient with a life expectancy of 30 additional years
and annual follow-up examinations with contrast-enhanced
chestCT,thecumulativeCTeﬀectivedosewouldbe210mSv,
signiﬁcantly increasing malignancy risk. Furthermore, the
risk for radiation-induced cancer is greater in a younger
patient (e.g., typical trauma victim) versus an older patient
[29]. Overall, the beneﬁt of lifelong annual CT scans for
assessing endograft status may be, to a degree, oﬀset by
the elevated risk of cancer due to high lifelong exposure to
ionizing radiation.
3.5. Potential for VOMIT. Concomitant with the advent
of high-resolution helical CT scanning for the diagnosis
of suspected BTAI, identiﬁcation of minimal aortic lesions
has become increasingly prevalent. Approximately 10% of
patients with BTAI experience minimal aortic injuries that
result in focal intimal tears with no or little involvement
of the media [30]. However, 21% of BTAI patients with
minimal aortic injuries undergo TEVAR [15] despite the
clinical practice guidelines of the Society of Vascular Surgery
to the contrary [31]. In vitro and in vivo animal studies
have demonstrated that arterial injuries limited to the intima
and inner media heal completely with no intervention [32–
35]. Malhotra and colleagues reported no aortic ruptures
in 9 patients with minimal traumatic aortic injuries who
underwent nonoperative management [30]. On balance, the
deﬁnition of minimal is ambiguous and the natural history
of these injuries may include pseudoaneurysm development
in up to 50% of cases [30]. Nonetheless, there is growing
concern that minimal aortic injury identiﬁed on CT com-
bined with the widespread enthusiasm for stent grafting
may result in unnecessary TEVAR treatment. The subset
of patients who are unnecessarily subjected to TEVAR in
the presence of a minimal BTAI, otherwise referred to as
VOMIT (Victims of Modern Imaging Technology) [36],
are subjected to unnecessary procedural- and device-related
risks given the overall favorable prognosis of untreated
minimal aortic injury. While not a long-term complication
per se, these patients are prone to all long-term device risks
previouslymentioned(includinga20%riskofdevice-related
complication in the postoperative period [15]) when, in
fact, they arguably could have been successfully treated with
nonoperative measures.
4. Summary
Evaluation of long-term complications following TEVAR for
BTAI is best managed by regular clinical and radiographical
patientfollowup.However,thetypicalBTAIpatientisnotori-
ously unreliable in attending scheduled follow-up visits [37–
39]. In fact, one study of TEVAR for BTAI reported that
70% of patients did not return for follow-up imaging after
hospital discharge despite patient education before discharge
and aggressive attempts at patient contact after discharge
[40]. Therefore, the potential for long-term complications of
TEVAR for treatment of BTAI may be further exaggerated
by the lack of ongoing medical surveillance. Even as stent
graft manufacturers continue eﬀorts to develop trauma-
speciﬁc endografts, the issues of continued aortic expansion,
unknowndevicedurability,excessiveradiationexposure,and
the potential for VOMIT remain. In conclusion, despite
the unmistakable short-term beneﬁt of TEVAR in the BTAI
patient, there is a largely unrecognized potential for serious
long-term complications with this procedure.
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